See Dow Development Laboratories’ FormulationForum for blogs and articles on various topical drug product development topics of interest.
October 1, 2021
Suspending an API in a topical drug product can be an appropriate alternative to a dissolved API, and can lead to better product outcomes. The potential advantages associated with suspensions are sometimes overlooked when developing topical formulations.
August 30, 2021
Acneic skin can involve inflammation, comedones, excess sebum production and bacteria.
May 7, 2021
If you’re not part of the solution, you’re the precipitate: Solubility studies are an essential first step in topical formulation development. Read about the factors to consider when designing a solubility study for an API for use in a topical drug product.
May 5, 2021
Topical nonsterile Rx products are at risk for contamination. Inclusion of an appropriate preservative system and USP testing will ensure that the product is free of microbial contamination.